Pulmonary Fibrosis

On October 14, 2020, Glenmark Pharma revealed that its launch NINDANIB, a generic version of Nintedanib, was effective to treat cases of pulmonary fibrosis. The drug has been cleared by Indian drug regulatory authorities. Glenmark Pharmaceuticals Glenmark Pharma has its generic drug markets across South America, the EU, U.S., and India. It has been a […]